Regulation of platelet glycoprotein VI (GPVI) surface expression and of soluble GPVI in patients with atrial fibrillation (AF) and acute coronary syndrome (ACS)

go back to reference Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, Chavey WE 2nd, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Smith SC Jr, Jacobs AK, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B (2007) ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients with Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 116:e148–e3044PubMedCrossRef Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, Chavey WE 2nd, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Smith SC Jr, Jacobs AK, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B (2007) ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients with Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 116:e148–e3044PubMedCrossRef

go back to reference Andrews RK, Karunakaran D, Gardiner EE, Berndt MC (2007) Platelet receptor proteolysis: a mechanism for downregulating platelet reactivity. Arterioscler Thromb Vasc Biol 27:1511–1520PubMedCrossRef Andrews RK, Karunakaran D, Gardiner EE, Berndt MC (2007) Platelet receptor proteolysis: a mechanism for downregulating platelet reactivity. Arterioscler Thromb Vasc Biol 27:1511–1520PubMedCrossRef

go back to reference Bigalke B, Geisler T, Stellos K, Langer H, Daub K, Kremmer E, Seizer P, May AE, Lindemann S, Gawaz M (2008) Platelet collagen receptor glycoprotein VI as a possible novel indicator for the acute coronary syndrome. Am Heart J 156:193–200PubMedCrossRef Bigalke B, Geisler T, Stellos K, Langer H, Daub K, Kremmer E, Seizer P, May AE, Lindemann S, Gawaz M (2008) Platelet collagen receptor glycoprotein VI as a possible novel indicator for the acute coronary syndrome. Am Heart J 156:193–200PubMedCrossRef

go back to reference Bigalke B, Lindemann S, Ehlers R, Seizer P, Daub K, Langer H, Schonberger T, Kremmer E, Siegel-Axel D, May AE, Gawaz M (2006) Expression of platelet collagen receptor VI is associated with acute coronary syndrome. Eur Heart J 27:2165–2169PubMedCrossRef Bigalke B, Lindemann S, Ehlers R, Seizer P, Daub K, Langer H, Schonberger T, Kremmer E, Siegel-Axel D, May AE, Gawaz M (2006) Expression of platelet collagen receptor VI is associated with acute coronary syndrome. Eur Heart J 27:2165–2169PubMedCrossRef

go back to reference Berndt MC, Karunakaran D, Gardiner EE, Andrews RK (2007) Programmed autologous cleavage of platelet receptors. J Thromb Haemost 5(Suppl 1):212–219PubMedCrossRef Berndt MC, Karunakaran D, Gardiner EE, Andrews RK (2007) Programmed autologous cleavage of platelet receptors. J Thromb Haemost 5(Suppl 1):212–219PubMedCrossRef

go back to reference Blann AD (2004) Angiogenesis and platelets: the clot thinkens further. Cardiovasc Res 63:192–193PubMedCrossRef Blann AD (2004) Angiogenesis and platelets: the clot thinkens further. Cardiovasc Res 63:192–193PubMedCrossRef

go back to reference Blann AD, Choudhury A, Freestone B, Patel J, Lip GY (2008) Soluble CD40 ligand and atrial fibrillation: relationship to platelet activation, and endothelial damage/dysfunction. Int J Cardiol 127:135–137PubMedCrossRef Blann AD, Choudhury A, Freestone B, Patel J, Lip GY (2008) Soluble CD40 ligand and atrial fibrillation: relationship to platelet activation, and endothelial damage/dysfunction. Int J Cardiol 127:135–137PubMedCrossRef

go back to reference Bolin RB, Cheney BA, Simpliciano OA, Peck CC (1980) In vitro evaluation of platelets stored in CDP-adenine formulations. Transfusion 20:409–418PubMedCrossRef Bolin RB, Cheney BA, Simpliciano OA, Peck CC (1980) In vitro evaluation of platelets stored in CDP-adenine formulations. Transfusion 20:409–418PubMedCrossRef

go back to reference Choudhury A, Chung I, Blann AD, Lip GY (2007) Elevated platelet microparticle levels in nonvalvular atrial fibrillation: relationship to p-selectin and antithrombotic therapy. Chest 131:809–815PubMedCrossRef Choudhury A, Chung I, Blann AD, Lip GY (2007) Elevated platelet microparticle levels in nonvalvular atrial fibrillation: relationship to p-selectin and antithrombotic therapy. Chest 131:809–815PubMedCrossRef

go back to reference Choudhury A, Chung I, Blann AD, Lip GYH (2007) Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet p-selectin as indexes of platelet function in atrial fibrillation. J Am Coll Cardiol 49:1957–1964PubMedCrossRef Choudhury A, Chung I, Blann AD, Lip GYH (2007) Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet p-selectin as indexes of platelet function in atrial fibrillation. J Am Coll Cardiol 49:1957–1964PubMedCrossRef

go back to reference Conway DS, Pearce LA, Chin BS, Hart RG, Lip GY (2002) Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1,321 patients with non-valvular atrial fibrillation: relationship to stroke risk factors. Circulation 106:1962–1967PubMedCrossRef Conway DS, Pearce LA, Chin BS, Hart RG, Lip GY (2002) Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1,321 patients with non-valvular atrial fibrillation: relationship to stroke risk factors. Circulation 106:1962–1967PubMedCrossRef

go back to reference D’Agostino RB Jr (1998) Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17:2265–2281PubMedCrossRef D’Agostino RB Jr (1998) Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17:2265–2281PubMedCrossRef

go back to reference Gardiner EE, Arthur JF, Kahn ML, Berndt MC, Andrews RK (2004) Regulation of platelet membrane levels of glycoprotein VI by a platelet-derived metalloproteinase. Blood 104:3611–3617PubMedCrossRef Gardiner EE, Arthur JF, Kahn ML, Berndt MC, Andrews RK (2004) Regulation of platelet membrane levels of glycoprotein VI by a platelet-derived metalloproteinase. Blood 104:3611–3617PubMedCrossRef

go back to reference Gardiner EE, Karunakaran D, Shen Y, Arthur JF, Andrews RK, Berndt MC (2007) Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteinases. J Thromb Haemost 5:1530–1537PubMedCrossRef Gardiner EE, Karunakaran D, Shen Y, Arthur JF, Andrews RK, Berndt MC (2007) Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteinases. J Thromb Haemost 5:1530–1537PubMedCrossRef

go back to reference Goto S, Tamura N, Handa S, Arai M, Kodama K, Takayama H (2002) Involvement of glycoprotein VI in platelet thrombus formation on both collagen and von Willebrand factor surfaces under flow conditions. Circulation 106:266–272PubMedCrossRef Goto S, Tamura N, Handa S, Arai M, Kodama K, Takayama H (2002) Involvement of glycoprotein VI in platelet thrombus formation on both collagen and von Willebrand factor surfaces under flow conditions. Circulation 106:266–272PubMedCrossRef

go back to reference Hamm CW, Goldmann BU, Heeschen C, Kreymann G, Berger J, Meinertz T (1997) Emergency room triage with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med 337:1648–1653PubMedCrossRef Hamm CW, Goldmann BU, Heeschen C, Kreymann G, Berger J, Meinertz T (1997) Emergency room triage with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med 337:1648–1653PubMedCrossRef

go back to reference Kälsch T, Elmas E, Nguyen XD, Suvajac N, Klüter H, Borggrefe M, Dempfle CE (2007) Endotoxin-induced effects on platelets and monocytes in an in vivo model of inflammation. Basic Res Cardiol 102:460–466PubMedCrossRef Kälsch T, Elmas E, Nguyen XD, Suvajac N, Klüter H, Borggrefe M, Dempfle CE (2007) Endotoxin-induced effects on platelets and monocytes in an in vivo model of inflammation. Basic Res Cardiol 102:460–466PubMedCrossRef

go back to reference Laske C, Leyhe T, Stransky E, Eschweiler GW, Bueltmann A, Langer H, Stellos K, Gawaz M (2008) Association of platelet-derived soluble glycoprotein VI in plasma with Alzheimer’s disease. J Psychiatr Res 42:746–751PubMedCrossRef Laske C, Leyhe T, Stransky E, Eschweiler GW, Bueltmann A, Langer H, Stellos K, Gawaz M (2008) Association of platelet-derived soluble glycoprotein VI in plasma with Alzheimer’s disease. J Psychiatr Res 42:746–751PubMedCrossRef

go back to reference Lip GYH (2003) The prothrombotic state in atrial fibrillation: the atrium, the endothelium… and tissue factor? Thromb Res 111:133–135PubMedCrossRef Lip GYH (2003) The prothrombotic state in atrial fibrillation: the atrium, the endothelium… and tissue factor? Thromb Res 111:133–135PubMedCrossRef

go back to reference Lip GY, Tse HF (2007) Management of atrial fibrillation. Lancet 370:604–618PubMedCrossRef Lip GY, Tse HF (2007) Management of atrial fibrillation. Lancet 370:604–618PubMedCrossRef

go back to reference Massberg S, Konrad I, Bultmann A, Schulz C, Münch G, Peluso M, Lorenz M, Schneider S, Besta F, Müller I, Hu B, Langer H, Kremmer E, Rudelius M, Heinzmann U, Ungerer M, Gawaz M (2004) Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo. FASEB J 18:397–399PubMed Massberg S, Konrad I, Bultmann A, Schulz C, Münch G, Peluso M, Lorenz M, Schneider S, Besta F, Müller I, Hu B, Langer H, Kremmer E, Rudelius M, Heinzmann U, Ungerer M, Gawaz M (2004) Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo. FASEB J 18:397–399PubMed

go back to reference Nieswandt B, Watson SP (2003) Platelet-collagen interaction: is GPVI the central receptor? Blood 102:449–461PubMedCrossRef Nieswandt B, Watson SP (2003) Platelet-collagen interaction: is GPVI the central receptor? Blood 102:449–461PubMedCrossRef

go back to reference Rabie T, Varga-Szabo D, Bender M, Pozgaj R, Lanza F, Saito T, Watson SP, Nieswandt B (2007) Diverging signaling events control the pathway of GPVI down-regulation in vivo. Blood 110:529–535PubMedCrossRef Rabie T, Varga-Szabo D, Bender M, Pozgaj R, Lanza F, Saito T, Watson SP, Nieswandt B (2007) Diverging signaling events control the pathway of GPVI down-regulation in vivo. Blood 110:529–535PubMedCrossRef

go back to reference Rosenbaum PR, Rubin DB (1983) The central role of the propensity score in observational studies for causal effects. Biometrika 70:41–55CrossRef Rosenbaum PR, Rubin DB (1983) The central role of the propensity score in observational studies for causal effects. Biometrika 70:41–55CrossRef

go back to reference Rudner LM, Peyton J (2006) Consider propensity scores to compare treatments. PARE 11:1–9 Rudner LM, Peyton J (2006) Consider propensity scores to compare treatments. PARE 11:1–9

go back to reference Schulz C, Penz S, Hoffmann C, Langer H, Gillitzer A, Schneider S, Brandl R, Seidl S, Massberg S, Pichler B, Kremmer E, Stellos K, Schönberger T, Siess W, Gawaz M (2008) Platelet GPVI binds to collagenous structures in the core region of human atheromatous plaque and is critical for atheroprogression in vivo. Basic Res Cardiol 103:356–367PubMedCrossRef Schulz C, Penz S, Hoffmann C, Langer H, Gillitzer A, Schneider S, Brandl R, Seidl S, Massberg S, Pichler B, Kremmer E, Stellos K, Schönberger T, Siess W, Gawaz M (2008) Platelet GPVI binds to collagenous structures in the core region of human atheromatous plaque and is critical for atheroprogression in vivo. Basic Res Cardiol 103:356–367PubMedCrossRef

go back to reference Steg PG, Bhatt DL, Wilson PW, D’Agostino R Sr, Ohman EM, Röther J, Liau CS, Hirsch AT, Mas JL, Ikeda Y, Pencina MJ, Goto S (2007) One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 297: 1197–1206PubMedCrossRef Steg PG, Bhatt DL, Wilson PW, D’Agostino R Sr, Ohman EM, Röther J, Liau CS, Hirsch AT, Mas JL, Ikeda Y, Pencina MJ, Goto S (2007) One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 297: 1197–1206PubMedCrossRef

go back to reference Stephens G, Yan Y, Jandrot-Perrus M, Villeval JL, Clemetson KJ, Phillips DR (2005) Platelet activation induces metalloproteinase-dependent GP VI cleavage to down-regulate platelet reactivity to collagen. Blood 105:186–191PubMedCrossRef Stephens G, Yan Y, Jandrot-Perrus M, Villeval JL, Clemetson KJ, Phillips DR (2005) Platelet activation induces metalloproteinase-dependent GP VI cleavage to down-regulate platelet reactivity to collagen. Blood 105:186–191PubMedCrossRef

go back to reference Yip HK, Chang LT, Sun CK, Yang CH, Hung WC, Hang CL, Wu CJ, Chua S, Yeh KH, Chang HW (2006) Platelet activation in patients with chronic nonvalvular atrial fibrillation. Int Heart J 47:371–379PubMedCrossRef Yip HK, Chang LT, Sun CK, Yang CH, Hung WC, Hang CL, Wu CJ, Chua S, Yeh KH, Chang HW (2006) Platelet activation in patients with chronic nonvalvular atrial fibrillation. Int Heart J 47:371–379PubMedCrossRef